CollPlant Biotechnologies Ltd - SHS NEW (CLGN)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / SHS NEW
Number of holders
18
Total 13F shares, excl. options
1.55M
Shares change
-167K
Total reported value, excl. options
$10.6M
Value change
-$1.73M
Number of buys
8
Number of sells
-7
Price
$6.80

Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q3 2022

21 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q3 2022.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.55M shares .
Largest 10 shareholders include Roumell Asset Management, LLC (605K shares), INVESTMENT MANAGEMENT OF VIRGINIA LLC (404K shares), VILLERE ST DENIS J & CO LLC (286K shares), BROWN ADVISORY INC (73.8K shares), BENJAMIN F. EDWARDS & COMPANY, INC. (65.4K shares), LPL Financial LLC (28.1K shares), Zurcher Kantonalbank (Zurich Cantonalbank) (23.2K shares), SIMON QUICK ADVISORS, LLC (15.7K shares), JANE STREET GROUP, LLC (13.3K shares), and Private Advisor Group, LLC (12.9K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.